Skip to ContentSkip to Navigation
How to find us G.S. van Zuiden-van Houten

Publications

Abacept treatment for patients with early active primary Sjögren's syndrome: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL

Abatacept treatment for patients with early active primary Sjogren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)

Clinical phenotyping of primary Sjögren's patients using salivary gland ultrasonography - data from the RESULT cohort

ABATACEPT TREATMENT OF PATIENTS WITH EARLY ACTIVE PRIMARY SJOGREN'S SYNDROME - A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED PHASE III-STUDY (ASAP-III)

Clinical Phenotyping of Patients with Primary Sjogren's Syndrome Using Salivary Gland Ultrasonograhpy

Efficacy and Safety of Abatacept in Patients with Early Active Primary Sjogren's Syndrome - Open-label Extension Phase of a Randomized Controlled Phase III Trial

Sexual Dysfunction and Vaginal Dryness Are Common in Female Patients with Early, Active Primary Sjogren's Syndrome

Seksuele functie bij vrouwen met het primaire syndroom van Sjögren

The impact of primary Sjogren's syndrome on female sexual function

The Impact of Primary Sjogren's Syndrome on Female Sexual Function.

Read more